Long-acting drug delivery technologies and services

Long-acting drug delivery has emerged as the novel and advanced drug delivery system which manipulate the dosing regimen of the drug in the body in order to sustain its therapeutic level.

For additional details, please visit
https://www.rootsanalysis.com/....reports/long-acting- or email sales@rootsanalysis.com

TIL-based therapy: An Innovative Way to Treat Solid Tumors

Till date, several clinical trials have demonstrated the efficacy and therapeutic superiority (over conventional treatment options) of TIL therapies . Their tumor-cell killing efficiency is attributed to the fact that they are pre-sensitized to cancer specific antigens.
For additional details, please visit
https://www.rootsanalysis.com/....reports/til-therapie or email sales@rootsanalysis.com

Driven by the increasing adoption of non-viral drug delivery technologies in the healthcare sector, we anticipate The global non-viral drug delivery systems market for healthcare to grow at an annualized rate of ~14%, till 2035
The global demand for biologics currently holds the largest share in the non-viral drug delivery domain and is expected to show the similar trend in the coming years.
For additional details, please visit https://www.rootsanalysis.com/....reports/non-viral-dr or email sales@rootsanalysis.com

The mRNA synthesis and manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers.
For additional details, please visit
https://www.rootsanalysis.com/....reports/mrna-synthes or email sales@rootsanalysis.com

The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis


SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share

For additional details, please visit
https://www.rootsanalysis.com/....reports/sarm1-inhibi
or email sales@rootsanalysis.com